9 Meters Biopharma (OTC: NMTR.Q)
9 Meters Biopharma Return vs. S&P
| 1 Year | 5 Year | 5 Year Annualized | Since IPO |
|---|
9 Meters Biopharma Company Info
9 Meters Biopharma, Inc. is a clinical-stage biopharmaceutical company, which focuses on unmet needs in gastroenterology. Its pipeline includes drug candidates for short bowel syndrome (SBS), celiac disease, and three early-stage candidates for undisclosed rare diseases and/or unmet needs. The company is founded by Jay P. Madan and Kendyle Woodard in 2012 and is headquartered in Raleigh, NC.
News & Analysis
Why 9 Meters Biopharma Stock Is Soaring Today
Some of the company's executives are making notable moves.
Why Blue Apron, Tribune Media, and Innovate Biopharmaceuticals Slumped Today
From a massive share offering to a potentially scuttled merger, see why these three stocks fell today.
Why Innovate Biopharmaceuticals Stock Cratered Today
The high-flying biotech had its wings clipped after confirmation of a dilution-causing share offering.
3 Biotech Stocks That Soared This Week: Are They Buys?
Can these high-flying biotech stocks keep up their momentum?
Valuation
Related Stocks
Premium Investing Services
Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.